Abstract. In this study we evaluated the activation of the cytokine and growth factor responsive transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NFB) after different grades of neural damage in the immature rat brain using double immunocytochemical techniques and electron microscopy. Following neocortical N-methyl-Daspartate induced excitotoxic cell death, both these transcription factors are mainly activated in astrocytes, although microglia, endothelial cells, and neurons show transient activation at specific times and locations. Interestingly, activation of both transcription factors is only observed in cortical areas affected by severe tissue damage, neuronal degeneration, and blood-brain barrier (BBB) disruption. In contrast, the milder glial response occurring in the distal thalamus is not preceded by immunocytochemically detectable STAT3 and NFB activation, although microglial response, astroglial hypertrophy, and glial fibrillary acidic protein (GFAP) overexpression do occur. In the cortex, astrocytes show STAT3 and NFB activation already at 2 to 4 hours post-lesion, preceding cell hypertrophy and GFAP upregulation, and being maintained in the long-term formed glial scar. STAT3 and NFB activation in microglial cells is protracted and observed at 10 to 24 hours post-lesion. The early activation of both transcription factors in astroglial cells could contribute to the changes in gene expression leading to astrogliosis and the release of signalling molecules which may contribute to the subsequent activation of these transcription factors in microglial cells.
INTRODUCTION
Glial cells react to central nervous system (CNS) injury in different ways, by undergoing changes in their cytoskeleton, migrating, proliferating, and increasing expression of distinct families of genes such as major histocompatibility molecules (MHC), growth factors, cytokines, and antioxidant proteins, among others (1, 2) . Whether none, some, or all of these events occur will depend on the grade of neuronal death, axonal degeneration, tissue damage, and blood-brain barrier (BBB) disruption, that is to say, the microenvironment in which the glial response takes place.
In order to study how different postinjury environments may modulate the particular characteristics of the glial response, we used the cortex-thalamus system in the young brain as an appropriate experimental model (2) (3) (4) . Neocortical lesions performed during the second postnatal week in the rat, the period of postnatal plasticity, result in a sparing of subcortical connections and a lack of behavioral deficits (5-7) as a result of the important ability for cortical reorganization at this age due to undergoing sprouting (8) . Supporting this finding, we observed (in previous studies) that excitotoxin-induced neocortical lesions cause neuronal degeneration and BBB disruption in the injected cortex, but no massive tissue damage or BBB disruption in the corresponding thalamic nuclei (3) . Accordingly, our studies show that in the excitotoxically damaged cortex versus the distal thalamus, astroglial, and microglial protein upregulation and de novo gene expression display 2 different patterns (2) (3) (4) that are determined by still unknown mechanisms of glial cell activation.
In non-neural tissues, it is well established that the signal transducer and activator of transcription 3 (STAT3) and the nuclear factor kappa B (NFB) are transcription factors known to mediate cytokine and growth factor actions in immune cells regulating a variety of genes involved in inflammation, cellular adaptation to stress and cell death (Fig. 5 ) (9) (10) (11) (12) (13) . Activation of these transcription factors has also been implicated in the brain response to stress and damage, both after experimental injury (14) (15) (16) (17) and in neurodegenerative diseases (18) (19) (20) , and their target genes include several proteins involved in the glial response, such as glial fibrillary acidic protein (GFAP), metallothioneins, cell adhesion molecules, and MHC complexes (9, 21, 22) . These findings are not surprising as cytokines and growth factors are important intercellular messengers involved in neuronal-glial interrelationship and the crosstalk between injury-activated astrocytes and microglial cells, consequently modulating the glial cell response and the lesion outcome (23) (24) (25) (26) . In this regard, because STAT3 and NFB transcription factors are probable key steps in glial cell changes of gene expression, the aim of the present work was to analyze their possible involvement in the astroglial and microglial responses in the excitotoxically lesioned young neocortex and in the distal thalamus, and to correlate the activation of these factors with the morphologic and metabolic changes observed during the glial cell response. 
MATERIALS AND METHODS

Excitotoxic Lesions
Experimental animal work using Long-Evans black-hooded rats was conducted according to Spanish regulations in agreement with European Union directives. As previously described (3), 9-day-old pups were placed in a stereotaxic frame adapted for newborns (Kopf) under ether anesthesia. The skull was opened using a surgical blade, and 37 nmols of N-methyl-Daspartate (NMDA) (Sigma, M-3262) diluted in 0.15 l of saline solution (0.9% NaCl, pH 7.4) were injected into the right sensorimotor cortex (at the level of the coronal suture, 2 mm lateral of bregma and at a depth of 0.5 mm) using a 0.5 l Hamilton microsyringe. Control animals followed the same procedure but received an injection of 0.15 l of the vehicle saline solution. After being sutured, the pups were placed in an incubator and maintained at normothermia for 2 h before being returned to their mothers. This experimental procedure was approved by the ethical commission of Autonomous University of Barcelona. All efforts were made to minimize animal suffering in every step.
Tissue Processing
For the light microscopy study, 4 NMDA-lesioned animals and 2 saline controls for each survival time of 2, 4, and 10 hours and 1, 3, 5, 7, and 14 days after the injection, were anesthetized by ether inhalation and perfused intracardially for 10 minutes (min) with 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4). Brains were immersed in the same fixative for 2 h and were quickly frozen with dry CO 2 after being cryoprotected in a 30% sucrose solution in 0.1M phosphate buffer. Frozen coronal sections (30-to 40-m-thick) obtained in a cryostat were processed free-floating. Parallel sections were mounted on slides and stained for routine histological examination.
For the electron microscopy study, another group of animals was examined at 4 hours, 1, 3, or 7 days postinjection. After each survival time, and under ether anesthesia, NMDA injected animals and saline controls were perfused intracardially for 5 min with 4% paraformaldehyde, 0.05% glutaraldehyde, and 2% saturated solution of picric acid in 0.1M phosphate buffer (pH 7.4). Brains were immersed in the same fixative without glutaraldehyde for 2 h and vibratome sections of 50 m were obtained.
STAT3 and NFB Immunocytochemistry
Frozen free-floating sections were treated with buffer blocking (BB) (10% fetal calf serum in tris buffered saline (TBS)ϩ1% triton X-100) for 30 min, and incubated either with rabbit anti-mouse STAT3 primary antibody (SantaCruz Biotechnology, sc-482) ( (p65) primary antibody (SantaCruz Biotechnology, sc-109) (36 h at 4ЊC) diluted to 1:100 in BB. After rinsing, the sections were incubated at room temperature for 1 h with the Cy3 conjugated anti-rabbit secondary antibody (Amersham, PA-43004) in a 1:1000 dilution in BB.
A similar procedure was used for vibratome sections. However, triton X-100 was omitted in every step, and primary antibodies were detected using a biotinylated anti-rabbit secondary antibody (Amersham, RPN-1004) diluted to 1:200 and avidin-peroxidase (Dakopatts, P-364) at a 1:400 dilution. Finally, the peroxidase reaction product was visualized in 100 ml of tris buffer containing 50 mg DAB and 33 l hydrogen peroxide. As negative controls, sections were incubated in media lacking primary antibodies.
Double Immunocytochemical Techniques
We used double staining techniques for the simultaneous visualization of STAT3 and microglial cells (by tomato lectin histochemistry), or astroglial cells (by glial fibrillary acidic protein, GFAP, immunocytochemistry). Moreover double labelling of NFB and microglial cells or astroglial cells was performed using the same specific glial markers.
Free-floating sections immunoreacted for STAT3 or NFB were further processed for GFAP immunocytochemistry, as described elsewhere (4), by using the primary antibody rabbit anti-GFAP (Dakopatts, Z-0334) diluted to 1:1800, biotinylated anti-rabbit sheep antibody (Amersham, RPN-1004) diluted to 1:200 as the secondary antibody, and Cy2-conjugated avidin (Amersham, PA-42000) at a dilution of 1:1000. Sections for double staining with tomato lectin histochemistry were treated as described previously (27) by using the biotinylated lectin obtained from Lycopersicon esculentum (tomato) (Sigma, L-9389) diluted to 6 g/ml and Cy2-conjugated avidin (Amersham, PA-42000) at a dilution of 1:1000. Double stained sections were analyzed using a LEICA TCS 4D confocal microscope.
Electron Microscopy Processing
Selected vibratome sections immunoreacted for STAT3 or NFB were cut into smaller pieces and postfixed in osmium tetroxide 1% in 0.1M phosphate buffer (pH 7.4) for 1 h at room temperature. After rinsing in buffer, sections were dehydrated in graded ethanol and embedded in epon. Semithin sections were obtained and lightly stained with toluidine blue. Unstained ultrathin sections were observed under an electron microscope (Hitachi 7000).
RESULTS
Findings are presented in different sections, separating controls from NMDA-lesioned animals, and the transcription factor analyzed. Within each section, results are presented in relation to specific cell populations. Results are summarized in the Table.
STAT3 and NFB in Saline Controls
In both hemispheres of saline-injected controls, we observed weak cytoplasmic STAT3 staining in neurons, mainly in those located in cortical layer V. Moreover, strong STAT3 immunoreactivity was observed in the nucleus and cytoplasm of astrocytes in cortical layer I and the corpus callosum of postnatal animals up to 16 days of age in both hemispheres ( Fig. 2A-C) . In addition, meninges, ependymal cells, and choroid plexuses were also stained.
NFB immunoreactivity was observed in neurons throughout the brain, especially in the hypothalamus, and to a lesser extent in cortical layers II, V, and VI. Although labelling was seen mainly cytoplasmically, some neurons showed mild nuclear staining (Fig. 3A) . Astroglial cells in the developing corpus callosum were also mildly immunoreactive. Meninges, ependymal cilia, and choroid plexuses were also stained. In addition, some perivascular lectin-positive cells showed NFB labelling. These cells were seen homogeneously distributed over the brain until 1 day after saline solution injection and were not found in sham operated or normal postnatal day 9 animals. In NFB and STAT3 processed sections, some endothelial cell labelling was observed in all animals (Fig. 2C) . Interestingly, not all endothelial cells in a given blood vessel were labelled.
STAT3 in Cortical Areas of NMDA-lesioned Animals
In NMDA-injected animals, the neuronal labelling pattern was maintained, whereas changes in STAT3 activation were observed in glial cells.
STAT3-positive astrocytes cells were observed from 2 h postinjection. At this early time point, the activation of STAT3 in astrocytes (Fig. 1A) was evident before changes in GFAP labelling and cell morphology took place. Double labelled astrocytes were mainly located in the deep cortical layers and the adjacent corpus callosum and ← nuclear invaginations (arrow). Note that microglia/macrophages (M) are NFB-negative. Interestingly, at 3 days postinjury, some reactive astrocytes show cytoplasmic and nuclear NFB (arrows in E) and prominent endoplasmic reticulum (arrowheads in E). Some NFB-positive astrocytic processes are found wrapping neuronal debris (arrow in F). As shown in (G), at day 7, reactive astrocytes (A) in the glial scar present a NFB-positive cytoplasm with hypertrophied processes contacting blood vessels (bv). Nuclear labelling (arrows in H) is still found in some astrocytes. Note the bundles of gliofilaments (arrowheads in high magnification picture of H). At this time macrophages located in the perivascular space (ps) also showed NFB immunoreactivity (arrows in I). Scale bars: A-C, E, and G-I ϭ 2 m; D ϭ 4 m; F ϭ 15 m; high magnification in H ϭ 0.5 m.
showed nuclear and perinuclear STAT3 staining and cytoplasmic GFAP immunoreactivity (Fig. 1A) . Astrocytes showed a similar pattern of STAT3 labelling at 4 and 10 h postinjection (Fig. 2D ) when they progressively became more GFAP-positive (Fig. 1B) in the ipsilateral cortex and corpus callosum. Maximal astroglial STAT3 immunostaining was observed 1 day postinjection (Figs. 1D-E , 2E-G) when reactive astrocytes of the lesion site and the adjacent corpus callosum showed STAT3 labelling in the perinuclear cytoplasm and proximal projections (Fig.  1D ), but not all of them displayed nuclear staining (Fig.  2E-F) . Ultrastructurally, reactive astrocytes at this time point displayed intracellular myelin bodies and few gliofilaments (Fig. 2F) . At 3 days postinjection, reactive astrocytes presented prominent rough endoplasmic reticulum, light intracellular vacuoles and gliofilaments, and concentrated in the upper layers where the glial scar later formed. In general, highly hypertrophied astrocytes located inside the degenerating area showed stronger STAT3 binding (Fig. 1F) than mildly reactive astrocytes of peripheral areas, which displayed fainter STAT3 immunostaining. At longer survival times, reactive astrocytes forming the glial scar presented very abundant gliofilaments and dark vesicles. STAT3 labelling was seen ← detailed according to review articles on the topic (9, 12, 21, (61) (62) (63) . Abbreviations: AP-1, activator protein-1; CNTF, ciliary neurotrophic factor; COX-2, cyclooxygenase-2; CREB, cAMP responsive element binding protein; CSF-1, colony stimulating factor-1; EGF, epidermal growth factor; G-CSF, granulocyte-colony stimulating factor; Glu, glutamate; GFAP, glial fibrillary acidic protein; GR, glucocorticoid-bound receptor; ICAM-1, intercellular adhesion molecule-1; IEG, immediate early genes; IFN␣, interferon alpha; IL, interleukin; IL-1RI, IL-1 receptor I; iNOS, inducible nitric oxide synthase; MHC, major histocompatibility complex; NFB, nuclear factor kappa B; NGF, nerve growth factor; PDGF, platelet-derived growth factor; STAT3, signal transducer and activator of transcription 3; TNF, tumour necrosis factor; TNFRI, TNF receptor I. throughout the cytoplasm in these astrocytes, including blood vessel end-feet (Fig. 2H-I ). Astroglial nuclei showed characteristic nuclear invaginations, but only some of them were still STAT3-positive (Fig. 2H) .
Although previous studies indicate that microglial cells are already activated at 4 h post-lesion (see ref. 3 for more details) they were STAT3-negative at the early time points (Fig. 1C) . Interestingly, we only observed a pulse of microglial STAT3 at 1 day postinjection (Fig. 1E ) when a subpopulation of labelled microglial cells were found in the deep cortical layers at the caudal edge of the degenerating area. STAT3-positive microglial cells were never ameboid or pseudopodic in shape, but showed a ramified reactive morphology. In addition, as in saline controls, some endothelial cells were also STAT3-positive at all survival times (Fig. 2G) .
NFB in Cortical Areas of NMDA-Lesioned Animals
In excitotoxically lesioned animals, injured neurons at the lesion site showed NFB labelling from 2 h postinjection and until neuronal degeneration took place at days 1 to 3 ( Fig. 3B-C) . Ultrastructurally, at 4 h postinjury, 2 different populations of neuronal cells were distinguished (Fig. 3C) , namely, (i) neurons with signs of nuclear condensation lacking NFB labelling, and (ii) neurons with both cytoplasmic and nuclear NFB labelling displaying cytoplasm vacuolation but no nuclear condensation.
Astroglial cells labelled with NFB were observed in the lesion site from 10 h after the injection. At this early time point, although most astrocytes were negative, some astroglial cells showed nuclear staining (Fig. 3B) . However, from day 1 and until day 14 (the last survival time examined), all NFB-positive glial cells were identified as reactive astrocytes by their double labelling with GFAP ( Fig. 1K-L) . At 1 day postinjection, astrocytes showed NFB immunoreactivity in the soma and proximal projections (Figs. 1K, 3D ) and were mainly located in the upper and deeper cortical layers and the corpus callosum. Later, at day 3, NFB-positive astrocytes in the degenerating focus became strongly hypertrophied (Fig.  3E ) and displayed high gliofilament content and both nuclear and cytoplasmic labelling (Figs. 1L, 3F) . Moreover, some astrocytes with figures indicating phagocytic activity were identified (Fig. 3E) , showing NFB only in the cytoplasm full of vesicles. At day 7 post-lesion, NFB immunostaining diminished and highly hypertrophied astrocytes forming the glial scar presented NFB labelling mainly cytoplasmic (Fig. 3G) , although some nuclei remained positive (Fig. 3H) .
The NFB-labelled reactive microglial cells observed at 10 h post-lesion were identified by their strong lectin binding and their ameboid or pseudopodic shape (Fig.  1H, I ). They principally showed NFB immunoreactivity in the cytoplasm (Fig. 1I) and were mainly located in deep layers of the degenerating cortex and the adjacent corpus callosum. It should be noted that not all reactive microglial cells were NFB-positive at this time point, and that no NFB-positive microglial cells were observed at any other time (Fig. 1J) . However, as in saline control animals, strongly NFB-positive and tomato lectin-positive perivascular cells were found throughout the brain up to 1 day of survival (Fig. 1G) . Finally, we observed an important accumulation of NFB-positive macrophages (Fig. 3I ) in the perivascular space of blood vessels located in the glial scar at 7 days post-lesion. It is noteworthy that macrophages in the nervous parenchyma were NFB-negative at this time point.
Lack of Glial STAT3 and NFB in the Distal Thalamus of NMDA-lesioned Animals
Mild NFB and STAT3 cytoplasmic labelling was observed in neurons located in the ventrobasal (VB) complex of the contralateral and ipsilateral thalamus in all saline-injected controls and NMDA-lesioned animals (Fig. 4C, D) . No differences were observed within these groups and no NFB or STAT3-positive glial cells were seen at any time (Fig. 4B, D) . However, as described previously in more detail (3, 4) , microglial cells showed increased lectin binding and presented a characteristic reactive morphology (Fig. 4A) . Astroglial cells were hypertrophied and showed increased GFAP staining (Fig.  4B) .
DISCUSSION
In this study we have evaluated the activation of the transcription factors STAT3 and NFB after different grades of neural damage in the immature rat brain. Both of these transcription factors are mainly activated in astrocytes, although microglia, endothelial cells, and neurons show transient activation at specific times and locations (see results and discussion below). Interestingly, activation of these transcription factors is only observed in cortical areas affected by severe tissue damage, neuronal degeneration, and BBB disruption (3). In contrast, the milder glial response occurring in the distal thalamus is not preceded by immunocytochemically detectable STAT3 and NFB activation, although microglial response, astroglial hypertrophy, and GFAP upregulation do occur.
Neuronal NFB Activation
Cortical neurons show constitutive levels of activated NFB (see Results and refs. 28, 29) . Early after the excitotoxic lesion, possibly as a direct effect of NMDA, neuronal cells within the lesion site increased NFB activation. Neuronal injury is likely to activate intracellular mechanisms to produce molecules for cell survival and repair. Thus, we have observed that early after the excitotoxic insult, and in addition to NFB activation, cortical neurons express the immediate early genes c-fos and cjun (unpublished observations) and downregulate the expression of growth inhibitory factor (GIF) (30) , probably in an attempt to increase cell repair before subsequent death. However, the role of NFB activation after neuronal damage remains controversial, while this transcription factor has been implicated in the protection against oxidative stress by the expression of manganese superoxide dismutase (MnSOD) (31, 32) , other studies indicate that it may be involved in the excitotoxin-induced apoptosis (33) .
Astroglial Activation of STAT3 and NFB
Activation of these transcription factors in astrocytes of the excitotoxically-damaged cortex precedes upregulation of GFAP, cell hypertrophy, and metabolic changes (4) . Actually, genes implicated in reactive astrogliosis, such as GFAP or metallothionein I-II, have been shown to be modulated by STAT protein binding to their promoters (Fig. 5) (21, 22) . STAT3 activation implies its phosphorylation and either homodimerization or heterodimerization with STAT1 (12) . In this sense, STAT1 is activated following ischemic injury to the adult rat brain (34) , indicating that it may possibly contribute to glial gene expression changes after our excitotoxic lesions.
As depicted in Figure 5 , STAT3 and NFB functions take place inside the nucleus. Thus, it may be assumed that only an immunocytochemical nuclear detection of these transcription factors indicates true functional DNA binding activity. Nuclear translocation occurs very rapidly and we could not observe cytoplasmic labelling prior to nuclear detection. Therefore the late cytoplasmic presence of STAT3 and NFB may correspond to their inactivation process, probably indicating cessation of previously existent nuclear activity. However, as reactive astrocytes show cytoplasmic activity, at least until day 14, other unknown functions or regulatory mechanisms of these transcription factors may be involved. In this sense, it is known that activated STAT3 triggers the inositol-3-phosphate signal transduction pathway by binding to specific receptor cytoplasmic domains (35) and cooperates in the upregulation of stat3 gene transcription and protein expression (36) , which could also contribute to cytoplasmic accumulation.
Concerning the presence of activators, several STAT3 or NFB inducers (Fig. 5) have been demonstrated after excitotoxic-like ischemic injury. These include plateletderived growth factor (PDGF) (37) , epidermal growth factor (EGF) (38) , ciliary neurotrophic factor (CNTF) (39) , and the cytokines IL-6 (40, 41), IL-1ß, and tumour necrosis factor alpha (TNF␣) (42) . As several studies point to microglial cells as the major source of cytokines after brain damage (26, 43) , it is conceivable that cytokines released by microglia/macrophages trigger astroglial STAT3 and NFB activation.
Pulse of Microglial STAT3 and NFB Activation
A small subpopulation of reactive microglia located at the periphery of the lesion showed activated NFB or STAT3 at 10 h and 1 day postinjury, respectively. Because microglial reactivity was observed after 4 h postinjury (3), these pulses of STAT3 and NFB activation may occur once microglial cells are already activated and may represent a response to very specific stimuli since activation is selectively found in specific microglial cells, but not in neighboring ones.
In contrast, reactive microglia/macrophages are the only glial cells activating STAT3 after adult brain ischemia (14) , suggesting that both the developmental stage and the specific type of injury may modulate glial STAT3 activation. Moreover, strong microglial NFB activation has been described following in vitro treatment with lipopolysaccharide but not cytokines (44) (45) (46) , and in pathological situations that involve strong inflammatory processes and massive peripheral blood cell recruitment such as multiple sclerosis, experimental autoimmune encephalitis, and spinal cord injury (15, 20, 47) . On the other hand, NFB activation and expression of NFB-regulated genes are mainly or exclusively found in astrocytes after IL-1 or TNF␣ treatment in vitro (48) (49) (50) and following convulsant seizures (51), cerebral infarction (52), and postnatal excitotoxic injury (present work) where a massive cellular inflammatory response does not occur. Therefore, it seems likely that microglial NFB activation depends on the levels of very specific inducers and/or inactivating signals.
STAT3 and NFB Activation in Blood Vessels
Both STAT3 and NFB were observed in some endothelial cells throughout the brain in saline controls and lesioned animals. Moreover, some NFB-positive perivascular cells were found from 2 h until 10 h after saline or NMDA injection. Upon several stress situations, the NFB-inducing cytokines IL-1 and TNF␣ are released early in the periphery and trigger IL-6 induction (26). Accordingly, it has been reported that after several stimuli, endothelial cells can express a variety of STAT3 and/ or NFB-induced genes, including IL-6, IL-1, adhesion molecules, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and IB (53-56). However, not all endothelial cells in a certain blood vessel were labelled, and positive cells were not seen in all blood vessels, which could suggest that either very specific local stimuli are needed for endothelial STAT3 and NFB induction, or that there are different subsets of endothelial cells showing distinct patterns of transcription factor activation. Finally, it is interesting to note that, at 7 days post-lesion, macrophages located in the parenchyma remained NFB-negative, but those accumulating in the perivascular space of blood vessels near the glial scar were NFB-positive. This could be explained by the fact that these macrophages are likely to be entering the bloodstream, and therefore may be exposed to high concentrations of NFB inducers.
Lack of STAT3 and NFB Immunoreactivity in the Distal Thalamus
The lack of apparent neuronal death and the maintenance of BBB integrity in the thalamus (3) provide a much less disturbed environment that modulates a particular glial response that differs in many aspects from the reactivity observed in the injury site. The thalamic microglial response implies morphological changes, increased lectin binding, and major histocompatibility complex I, but not type II expression (3) . The astroglial reactivity is characterized by cell hypertrophy and increased GFAP expression, although reactive astrocytes do not express vimentin or the antioxidant protein metallothionein I-II, and do not form a long-term glial scar as they do in the lesion site (2, 4) . Interestingly, neither thalamic reactive astrocytes nor microglial cells show STAT3 or NFB immunoreactivity.
As no vasculature damage and no leukocyte recruitment takes place in the thalamus (3), we may assume that no inflammation occurs and that appropriate stimuli for STAT3 or NFB activation may not be provided in sufficient amounts. Until now, the presence of cytokines and growth factors in this specific experimental model was unknown, but some data is available from other studies using models of glial response distal from the injury site. These studies showed that neither expression of IL-1 or TNF␣ (potent inducers of NFB) or IL-6 (activator of STAT3) could be detected in the adult thalamus following cortical contusions (57), although IL-6 (but not IL-1 or TNF␣) was upregulated in the regenerative adult rat facial nucleus following motoneuron axotomy (58) . Therefore, it may be assumed that distal glial responses generally occur in the presence of low or undetectable levels of proinflammatory cytokines.
Another explanation for the absence of NFB and STAT3 activation in thalamic reactive glial cells could be the putative presence of inflammatory downregulators. Besides the upregulated expression after excitotoxicity (59) and ischemia (60) , it has been shown that reactive microglia express transforming growth factor beta-1 (TGF-ß1) in response to retrograde neuronal regeneration (58) and anterograde degeneration (59) , which may provide a negative feedback able to control the extent of the glial response when low levels of proinflammatory cytokines are present. The appropriate balance between proinflammatory cytokines and downregulating factors probably determines the extent of the glial response and the activation of inflammation-associated transcription factors. In this sense, further work is needed to elucidate the putative signals involved in the glial response found in distal areas.
